Waystar Holding Corp. (NASDAQ: WAY) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
24.70
+0.47+1.94%
TA
Loading chart...
Snapshot
| Index | - | P/E | 33.65 | EPS (ttm) | 0.72 | Insider Own | - | Shs Outstand | 191.75M | Perf Week | 14.78% |
| Market Cap | 4.65B | Forward P/E | 12.95 | EPS next Y | 1.87 | Insider Trans | -0.05% | Shs Float | 139.64M | Perf Month | 4.53% |
| Enterprise Value | 6.12B | PEG | 0.76 | EPS next Q | 0.41 | Inst Own | - | Short Float | 9.73% | Perf Quarter | 15.33% |
| Income | 134.74M | P/S | 3.85 | EPS this Y | 137.44% | Inst Trans | - | Short Ratio | 5.03 | Perf Half Y | 0.41% |
| Sales | 1.21B | P/B | 1.17 | EPS next Y | 12.58% | ROA | 2.30% | Short Interest | 13.59M | Perf YTD | -26.02% |
| Book/sh | - | P/C | 15.87 | EPS next 5Y | 12.21% | ROE | 3.59% | 52W High | 42.27 -41.57% | Perf Year | -28.71% |
| Cash/sh | - | P/FCF | 18.87 | EPS past 3/5Y | - | ROIC | 3.37% | 52W Low | 17.60 40.38% | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 14.14 | Sales past 3/5Y | 15.95% - | Gross Margin | 69.11% | Volatility | 4.27% 4.56% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.07 | EPS Y/Y TTM | 638.46% | Oper. Margin | 22.87% | ATR (14) | 1.30 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.85 | Sales Y/Y TTM | 27.86% | Profit Margin | 11.18% | RSI (14) | 58.95 | Recom | 1.94 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.85 | EPS Q/Q | 19.44% | SMA20 | 7.06% | Beta | 0.58 | Target Price | 33.15 |
| Payout | 0.00% | Debt/Eq | 0.37 | Sales Q/Q | 18.08% | SMA50 | 14.59% | Rel Volume | 1.71 | Prev Close | 24.23 |
| Employees | 1,700 | LT Debt/Eq | 0.38 | Earnings | Nov 04 | SMA200 | -8.47% | Avg Volume | 2.74M | Price | 24.70 |
| IPO Date | Jun 07, 2024 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 8.05% 1.10% | Net Debt/EBITDA | 3.40 | Volume | 4,669,376 | Change | 1.94% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-07-26 | Reiterated | Barclays | Overweight | $25 → $27 |
| Jul-31-26 | Reiterated | Deutsche Bank | Buy | $36 → $39 |
| Jul-30-26 | Reiterated | UBS | Buy | $34 → $33 |
| Jul-30-26 | Reiterated | Wells Fargo | Overweight | $36 → $33 |
| Jul-20-26 | Reiterated | UBS | Buy | $37 → $34 |
| Jul-01-26 | Initiated | KeyBanc | Overweight | $30 |
| Apr-30-26 | Reiterated | Raymond James | Strong Buy | $35 → $32 |
| Apr-30-26 | Reiterated | UBS | Buy | $41 → $37 |
| Mar-05-26 | Reiterated | Raymond James | Strong Buy | $30 → $35 |
| Feb-19-26 | Reiterated | Wells Fargo | Overweight | $41 → $36 |
Latest News
Aug-05-26
Aug-03-26
12:41PM
Jul-29-26
09:04PM
Waystar Q2 Earnings Call Highlightsmarketbeat.com
07:31PM
06:26PM
04:05PM
04:05PM
Waystar Reports Second Quarter 2026 Resultsprnewswire.com
03:37AM
Jul-22-26
Jul-22-2611:01AM
Jul-21-26
Jul-21-2605:00PM
Jul-16-26
Jul-16-2608:00AM
Jul-15-26
Jul-15-2608:00AM
Company
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | |
|---|---|---|---|---|---|---|---|
| Total Revenue | 1,207 | 1,099 | 944 | — | — | — | |
| Cost of Goods Sold Incl. D&A | 373 | 348 | 316 | — | — | — | |
| Gross Profit | 834 | 751 | 628 | — | — | — | |
| Selling, General and Administrative Excl. Other | 335 | 307 | 269 | — | — | — | |
| Research and Development | 67 | 55 | 49 | — | — | — | |
| Other Operating Expense | 155 | 140 | 186 | — | — | — | |
| Operating Income | 275 | 249 | 124 | — | — | — | |
| Interest Expense | 82 | 78 | 146 | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 0 | 0 | 0 | — | — | — | |
| Net Income Before Taxes | 195 | 172 | -23 | — | — | — | |
| Income Taxes | 61 | 60 | -3 | — | — | — | |
| Consolidated Net Income | 135 | 112 | -19 | — | — | — | |
| Net Income From Continuing Operations | 135 | 112 | -19 | — | — | — | |
| Net Income | 135 | 112 | -19 | — | — | — | |
| EPS (Recurring) | 0.72 | 0.63 | -0.13 | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.72 | 0.63 | -0.13 | — | — | — | |
| EPS (Diluted) | 0.70 | 0.61 | -0.13 | — | — | — | |
| EBITDA | 433 | 390 | 310 | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | |
| Price To Earnings Ratio | 35.29 | 53.69 | — | — | — | — | |
| Price To Sales Ratio | 3.93 | 5.30 | 5.83 | — | — | — | |
| Gross Margin | 69.10 | 68.33 | 66.53 | — | — | — | |
| Operating Margin | 22.78 | 22.66 | 13.14 | — | — | — | |
| Net Margin | 11.18 | 10.19 | -2.01 | — | — | — | |
| Shares Outstanding | 192 | 178 | 150 | — | — | — | |
| Market Capitalization | 4,742 | 5,830 | 5,505 | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Hawkins Matthew J. | Chief Executive Officer | Jul 16 '26 | Option Exercise | 4.14 | 36,901 | 152,770 | 963,717 | Jul 17 |
| Hawkins Matthew J. | Chief Executive Officer | Jul 16 '26 | Sale | 23.09 | 36,901 | 851,944 | 926,816 | Jul 17 |
| Hawkins Matthew J. | Chief Executive Officer | Jul 15 '26 | Sale | 23.02 | 33,099 | 762,032 | 926,816 | Jul 17 |
| Hawkins Matthew J. | Chief Executive Officer | Jul 15 '26 | Option Exercise | 4.14 | 33,099 | 137,030 | 959,915 | Jul 17 |
| MILLER HEIDI | Director | Mar 02 '26 | Buy | 26.25 | 7,200 | 188,986 | 7,200 | Mar 03 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Jan 20 '26 | Option Exercise | 6.78 | 40,225 | 272,778 | 515,051 | Jan 22 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Jan 20 '26 | Sale | 30.08 | 40,225 | 1,210,077 | 474,826 | Jan 22 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Dec 22 '25 | Option Exercise | 4.14 | 9,701 | 40,162 | 484,527 | Dec 23 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Dec 22 '25 | Sale | 32.82 | 9,701 | 318,396 | 474,826 | Dec 23 |
| Schremser Christopher L. | Chief Technology Officer | Dec 10 '25 | Option Exercise | 4.14 | 8,623 | 35,699 | 430,994 | Dec 11 |
| Schremser Christopher L. | Chief Technology Officer | Dec 10 '25 | Sale | 30.41 | 8,623 | 262,225 | 422,371 | Dec 11 |
| Miller Melissa F. (Missy) | Chief Marketing Officer | Nov 25 '25 | Option Exercise | 18.19 | 3,400 | 61,846 | 196,661 | Nov 26 |
| Miller Melissa F. (Missy) | Chief Marketing Officer | Nov 25 '25 | Sale | 37.00 | 3,400 | 125,800 | 193,261 | Nov 26 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Nov 20 '25 | Option Exercise | 4.14 | 9,701 | 40,162 | 484,527 | Nov 21 |
| Sinclair III Eric L. (Ric) | Chief Business Officer | Nov 20 '25 | Sale | 35.27 | 9,701 | 342,181 | 474,826 | Nov 21 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.